A systemic bioactivity comparison of double-strength and regular- strength beclomethasone dipropionate MDI formulations

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 1, 1998, Pages 39-44

  Brannan, Melvin D ^a   Herron, Jerry M ^b   Reidenberg, Pascale ^a   Affrime, Melton B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Research Solutions LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; HYDROCORTISONE; PLACEBO; PREDNISONE; TETRACOSACTIDE;

ADRENAL CORTEX FUNCTION; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MYALGIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0031908930     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62937-7     Document Type: Article

References (15)

1. International Asthma Management Project. National Heart, Lung, and Blood Institute. National Institutes of Health. International Consensus Report on Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; March 1992. Publication No. 92-3091.
2. National Asthma Education Program. Office of Prevention, Education, and Control. National Heart, Lung, and Blood Institute. National Institutes of Health. Executive Summary: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; June 1991. Publication No. 91-3042A.
3. Skorodin MS. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies. Arch Intern Med 1993;153:814-28.
4. Boulet L-P, Giguère M-C, Milot J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994;94: 796-803.
5. Davies B. A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma. Br J Clin Pract 1993;47:87-93.
6. Svendsen UG, Frolund L, Heinig JH, et al. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy 1992;47:174-80.
7. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148(suppl):S1-S26.
8. Kaliner MA. Goals of asthma therapy. Ann Allergy, Asthma Immunol 1995; 75:169-72.
9. Huskisson SC, Meades CR, Cass FMC, Palmer JBD, ed. Inhaled beclomethasone dipropionate: systemic effects reviewed. Abersytwyth: Castle Press; 1987:5-14.
10. Complete Prescribing Information for Vanceril (beclomethasone dipropionate/Schering). In: Physicians' desk reference. 49th ed. Montvale, NJ: Medical Economics Data Production Co, 1996:2394-5.
11. Complete Prescribing Information for Azmacort (triamcinolone acetonide/ Rhône-Poulenc Rorer). In: Physicians' desk reference, 49th ed. Montvale, NJ: Medical Economics Data Production Co, 1996:2011-3.
12. Complete Prescribing Information for Aerobid (flunisolide/Forest Laboratories, Inc.) In: Physicians' desk reference. 49th ed. Montvale, NJ: Medical Economics Data Production Co, 1996: 1005-9.
13. Feiss G, Morris R, Dror R, et al. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. J Allergy Clin Immunol 1992;89:1151-6.
14. Meltzer EO, Kemp JP, Welch MJ, Orgel HA. Effect of dosing schedule on efficacy of beclomethasone dipropionate aerosol in chronic asthma. Am Rev Respir Dis 1985;131:732-6.
15. Kabra P, Tsai L, Marton L. Improved liquid-chromatographic method for determination of serum cortisol. Clin Chem 1979;25:1293-6.